Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen - CNBC
AI Summary1 min read
TL;DR
Eli Lilly introduces a multi-dose KwikPen for Zepbound, offering a month's worth of obesity drug doses in one pen after FDA approval.
Tags
Eli LillyZepboundobesity drugmulti-dose penFDA approval
- Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen CNBC
- Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen Eli Lilly
- Eli Lilly’s Zepbound Gets FDA OK for Multi-Dose Pen The Wall Street Journal
- Lilly adds multidose Zepbound pens to self-pay menu after FDA nod Fierce Pharma
- Lilly to launch multi-dose weight-loss drug device in US Yahoo Finance